Examination Report |
1 | TM-1 | 16 Mar 2012 |
2 | Additional Representation Sheet | 16 Mar 2012 |
3 | Reply to Exam Report (MIS-R) | 13 Apr 2016 |
4 | Affidavit | 20 Sep 2017 |
5 | Hearing Notice | 03 Oct 2017 |
6 | Journal Copy | 12 Sep 2018 |
7 | Certificate | 19 Dec 2018 |
8 | TM-R(RENEWAL OF TRADE MARK) | 10 Jan 2022 |
9 | TM-P(SUBSEQUENT PROPRIETOR BY WAY OF ASSIGNMENT OR TRANSFER OF A SINGLE MARK) | 11 Jan 2023 |
1 | Dispatching of Examination Report for : 2300937 | 2746794 | 1369280 | 12 Jan 2016 |
2 | Abandoned Order for Application No 2300937 | 3301192 | 1679669 | 30 Mar 2016 |
3 | Hearing Notice (Show Cause) | 5059751 | 24 Aug 2017 | |
4 | Hearing Notice (Adjourned) | 6430571 | 2861591 | 29 May 2018 |
5 | Tribunal Accepted Notice for : 2300937 | 6715506 | 3034160 | 24 Jul 2018 |
6 | O3 NOTICE | 12636097 | 5422549 | 13 Dec 2021 |
7 | RENEWAL INTIMATION LETTER | 12887049 | 25 Jan 2022 |
As per IP India data the trademark was applied on 16 March 2012.
APOLLO HOSPITALS ENTERPRISE applied for Aceclochoice 100mg.
Listed class of trademark Aceclochoice 100mg is 5.
Aceclochoice 100mg is on the Registered stage of the trademark process.
Serial Number provided to trademark application is 2300937
The trademark is categorized as WORD.